First Japanese variant of late infantile neuronal ceroid lipofuscinosis caused by novel CLN6 mutations

Brain Dev. 2016 Oct;38(9):852-6. doi: 10.1016/j.braindev.2016.04.007. Epub 2016 May 7.

Abstract

The clinical phenotypes of neuronal ceroid lipofuscinoses (NCLs) have been determined based on the age of onset and clinical symptoms. NCLs with onset between age 2 and 4years are known as late infantile neuronal ceroid lipofuscinoses (LINCLs). The clinical features of LINCLs include visual loss and progressive myoclonus epilepsy (PME) characterized by myoclonus, seizures, ataxia, and both mental and motor deterioration. There have been reports of several genes associated with LINCLs, with mutations in the CLN6 gene reported to cause variant forms of LINCLs (vLINCLs). Here, we report the first Japanese vLINCL caused by novel CLN6 mutations, found in a patient diagnosed by whole-exome sequencing. Visual acuity in our patient was preserved until the early teens. It remains to be elucidated if preserved visual function is related to the novel mutations of CLN6. Our case reveals the efficacy of whole-exome sequencing for examination of PMEs and highlights the existence of the CLN6 mutation in the Japanese population.

Keywords: CLN6; Late infantile neuronal ceroid lipofudcinosis; Whole-exome sequencing.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Asian People / genetics
  • Brain / diagnostic imaging
  • Brain / physiopathology
  • DNA Mutational Analysis
  • Diagnosis, Differential
  • Electroencephalography
  • Humans
  • Japan
  • Magnetic Resonance Imaging
  • Male
  • Membrane Proteins / genetics*
  • Mutation*
  • Neuronal Ceroid-Lipofuscinoses / diagnosis*
  • Neuronal Ceroid-Lipofuscinoses / genetics*
  • Neuronal Ceroid-Lipofuscinoses / physiopathology
  • Sequence Homology, Amino Acid

Substances

  • CLN6 protein, human
  • Membrane Proteins